CVR: 42852287
Secondary names: Nordisk Pharma Denmark ApS, Nordisk Pharma Sweden ApS, Nordisk Pharma Norway ApS
DKK 365,248
Gross profit
Net result: DKK 207,225
Nordisk Pharma Holding ApS
CVR · view ownership and management
Director registered: Sayed Edris Sadat
CVR · 17/11/2021
View the full event history
Nordisk Pharma ApS is a Danish company of the type Anpartsselskab based in Vallensbæk, founded in 2021. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The management consists of Sayed Edris Sadat and Sanad Emad Hussein Al Bidany. The company is owned by Nordisk Pharma Holding ApS. In 2025, the company reported a gross profit of DKK 365,248 and a net result of DKK 207,225 compared with DKK 425,521 the year before. Equity in the 2025 report amounted to DKK 1,216,729.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Source: annual reports filed with the Danish Business Authority.
Compared to 309 companies in Fremstilling af medicinske og dentale instrumenter samt udstyr hertil
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreNordisk Pharma ApS was founded on 17 November 2021.
Nordisk Pharma ApS is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil (industry code 325000).
Nordisk Pharma ApS is owned by Nordisk Pharma Holding ApS.
In 2025, Nordisk Pharma ApS reported a gross profit of DKK 365,248.
The management of Nordisk Pharma ApS consists of Sayed Edris Sadat and Sanad Emad Hussein Al Bidany.
Nordisk Pharma ApS is located at Stenkløvervænget 21, 2625 Vallensbæk.
Claim this page to add your logo and social links. Free to get started.
Nordisk Pharma ApS has published its annual report for 2025. Gross profit came to DKK 365,248, and the net result was DKK 207,225.
Nordisk Pharma ApS has published its annual report for 2024. Gross profit came to DKK 552,864, and the net result was DKK 425,521.
Nordisk Pharma ApS has published its annual report for 2023. Gross profit came to DKK 331,910, and the net result was DKK 262,984.
Nordisk Pharma ApS has published its interim report for the period November 17, 2021 – December 31, 2022.
As of November 17, 2021, Sayed Edris Sadat is registered as adm. dir. of Nordisk Pharma ApS.
As of November 17, 2021, Sanad Emad Hussein Al Bidany is registered as director of Nordisk Pharma ApS.
As of November 17, 2021, Nordisk Pharma Holding ApS is registered as an owner of Nordisk Pharma ApS with an ownership share of 100%.
Nordisk Pharma ApS was founded on November 17, 2021.
Companies in the same industry and area
CVR 44141078
CVR 42640859
CVR 36578335
CVR 10054974
CVR 26094577
